From: Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
Protein | Age adjusted ROC AUC (95% CI) | Unadjusted ROC AUC (95% CI) | ||
---|---|---|---|---|
Ottawa Samples | Mayo Samples | Ottawa Samples | Mayo Samples | |
Age Only Model | 0.68 (0.53, 0.82) | 0.53 (0.36, 0.69) | Â | Â |
CAMK2A | 0.73 (0.60, 0.87) | 0.69 (0.53, 0.85) | 0.67 (0.51, 0.83) | 0.68 (0.53, 0.84) |
CNTNAP4_Q9C0A0 | 0.74 (0.60, 0.88) | 0.66 (0.50, 0.83) | 0.68 (0.53, 0.83) | 0.66 (0.50, 0.82) |
IGLON5 | 0.75 (0.61, 0.88) | 0.54 (0.36, 0.72) | 0.67 (0.52, 0.82) | 0.55 (0.36, 0.73) |
RTN4RL2* | 0.73 (0.59, 0.86) | 0.66 (0.50, 0.82) | 0.67 (0.51, 0.83) | 0.66 (0.49, 0.82) |
SEZ6L | 0.73 (0.60, 0.87) | 0.55 (0.38, 0.73) | 0.67 (0.52, 0.82) | 0.56 (0.37, 0.74) |
TMEM132D* | 0.71 (0.58, 0.85) | 0.64 (0.48, 0.79) | 0.69 (0.55, 0.84) | 0.64 (0.49, 0.79) |